CAPTRUST Financial Advisors’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
Other funds holding LFCR
CAPTRUST Financial Advisors's LFCR Position: Q3 2026 in Review
CAPTRUST Financial Advisors opened a new position in Lifecore Biomedical (LFCR) in Q3 2026: 11,170 shares worth $73.5K. The stake represents ﹤0.01% of the portfolio and ranks #3204 among its holdings.
105 funds tracked by Wall St. Rank hold LFCR as of Q3 2026.
- CAPTRUST Financial Advisors held 11,170 shares of Lifecore Biomedical worth $73.5K as of Q3 2026.
- Lifecore Biomedical was a new CAPTRUST Financial Advisors position in Q3 2026.
- Lifecore Biomedical made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q3 2026, its #3204 holding.
- 105 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q3 2026.
Based on CAPTRUST Financial Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.